St Jude recovers partial attorney fees in heart catheter case
26-10-2021
Abbott unit prevails in dispute over catheter patent
25-03-2021
Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute
05-11-2020
Ken Wolter / Shutterstock.com
Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Abbott Laboratories, Grifols Diagnostic, Novartis, HIV testing products, patent infringement, natural phenomenon, patent invalidity
